Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Freetrailer Group A/S Quarterly report Q3 2022-2023

After a Q3 with 10% revenue growth, Freetrailer sees positive signs of increased rental activity in Q4, especially in our international markets.In Q3 22/23, the number of rentals increased by 9% compared to the same period last year, and revenue grew by 10% compared to Q3 21/22. Freetrailer Group A/S presents a financial report for the first nine months of the fiscal year from July 1, 2022, to June 30, 2023.  Q3 GROUP KEY FIGURES IN DKK 1,000 (1 January 2023 - 31 January 2023)(the corresponding period last year is indicated in brackets) · Revenue 17,029.2 (15,483.2) ·

Strategy Update: Following a successful AGM, DecideAct aims to break even in 2024 after emerging stronger from a turbulent 2022

Yesterday, DecideAct held its annual general meeting, where the company’s CEO, Flemming Videriksen, took stock of 2022 and gave an update on the strategy. In 2022, DecideAct passed DKK 10 million in ARR, and the year thus marked the end of the company's first 10x growth journey. This result was achieved in a year when SaaS companies in general were severely challenged. Now DecideAct aims to break even in 2024.At the end of 2022, the growth in ARR was 37% gross and 14% net after churn. Like other SaaS companies, DecideAct was affected by many companies taking a step back and cutting their

BioStock: Alligator Bioscience awarded Orphan Drug Designation for mitazalimab

Lund-based Alligator Bioscience continues to increase the value of its lead asset mitazalimab. The company recently announced receiving Orphan Drug Designation for the CD-40 antibody from the FDA. BioStock contacted Jonas Henningsen, VP Regulatory Affairs at Alligator, and CEO Søren Bregenholt, to learn more about what this means for the project.Read the interview with Jonas Henningsen and Søren Bregenholt at biostock.se: Alligator Bioscience awarded Orphan Drug Designation for mitazalimab - BioStock 

Inhalation Sciences receives 125,000 EURO funding in cross-European research project on inhaled antibiotics and antibiotic resistance

(Stockholm, 25 May, 2023) Inhalation Sciences (ISAB) has been awarded 125,000 EURO for its role in the research project ‘New Inhalation Formulations for Improved Delivery of Antimicrobials’ (APRINHA). ISAB is one of seven organizations collaborating on this project, including RISE (the Research Institutes of Sweden.) ISAB announced that it had collaborated with RISE on a joint funding proposal for the project on June 9, 2022. The project will run for 36 months. It is being coordinated by the University of Zurich (UZH).The unmet need for a targeted, efficacious inhaled antibiotic treatment

INTERIM REPORT JANUARY 1st 2023 – MARCH 31st 2023

SELECTIMMUNE PHARMA IN BRIEF   · Antibiotic resistance is a global, rapidly growing health concern. The World Health Organization (WHO) has declared antibiotic resistance a major threat to global health. · SelectImmune Pharma is an innovative biotech company that develops novel therapies against infection. · These therapies are designed to inhibit excessive innate immune responses to infection, which are a major cause symptoms and pathology. · Several of the company’s drug candidates have shown protective effects against bacterial infection in animal models, including

Interim Report January – March 2023

ChromoGenics delivers to Denmark and begins cooperation in FranceQ1 2023 In Q1 2023, ChromoGenics’ net sales amounted to SEK 5.8 (8.5) million, a decrease of SEK 2.7 million compared to the corresponding quarter in 2022. The company made deliveries during the first quarter to, among others, Franska Skolan in Copenhagen, Denmark, which impacted net sales by SEK 2.5 million during the quarter. ChromoGenics’ operating loss for the first quarter of the year amounted to SEK -12.2(-16.8) million, which is an improvement of SEK 4.6 million compared to the corresponding period in 2022. The

Bluefors to acquire its distributor Rockgate, establishing direct presence in the Japanese cryogenics technology market

Publish Date: May 25, 2023, 9:00 EEST – 15:00 JST Helsinki, Finland; Tokyo, Japan   Bluefors, a leading Finnish manufacturer of cryogenic measurement systems, has today announced its acquisition of Rockgate, a distributor of cryogenic equipment, based in Tokyo, Japan. With the acquisition Bluefors will establish direct sales and service presence in the Japanese cryogenics technology market and expand its global footprint beyond Finland, Germany, the Netherlands, and USA.   “Rockgate became the first distributor for Bluefors in the early stages of our journey and they have

Catena Media announces share buybacks executed from 17 to 23 May 2023

Catena Media plc (LEI code: 549300609A73DL5C5Z86) repurchased 205,000 of its own ordinary shares (ISIN code: MT0001000109) from 17 to 23 May 2023 as part of its share buyback programme. The buyback programme (“the 2022 programme”) was authorised by shareholders at an extraordinary general meeting on 10 August 2022 and initiated and announced by the board of directors on 13 January 2023. The 2022 programme was implemented in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). Its

Kemira achieves EcoVadis Platinum level for the third consecutive year with an improved score of 80/100

Kemira Oyj, Press Release, May 25, 2023 at 9 am (EEST)  Kemira achieves EcoVadis Platinum level for the third consecutive year with an improved score of 80/100Kemira has once again achieved the Platinum level rating for its sustainability performance by EcoVadis, the global sustainability rating platform, for the third consecutive year. Kemira remains among the top 1% of companies rated worldwide, with a score increase of 2 points to 80/100 (compared to 78/100 in 2022) due to its progress in sustainable procurement through engagement with suppliers on climate-related issues as well as

Clinical Laserthermia Systems AB publishes interim report January – March 2023

Summary of the interim report (relates to the Group)   Three months (01/01/2023–03/31/2023) · Net sales totaled SEK 587,000 (SEK 708,000). · Profit/loss after financial items totaled SEK -21,464,000 (SEK -13,842,000). · Basic and diluted earnings per share totaled SEK -0.15 (SEK -0.21). · The equity ratio at March 31, 2022, was 7,5% (12%).     Significant events in the first quarter of 2023   · The twentieth and final patient was treated by the Urological Research Network, LCC, based in Florida, USA, in the phase 1 clinical trial using the CLS TRANBERG®

Interim report Q1 2023

First quarter January 1-March 31 2023 · Net sales amounted to 17,275 (8,217) kSEK, an increase of 110% compared to Q1 2022. · Operating profit before depreciation and amortization and shares in associated companies' earnings (EBITDA) amounted to -249 (963) kSEK after financial items amounted to -3,432 (-909) kSEK · EBITDA per share amounted to -0.01 (0.06) SEK · Earnings per share after financial items amounted to SEK -0.20 (-0.06) SEK · Cash and cash equivalents at the end of the quarter amounted to 17,893[1] (37,890) kSEK. This compares to 48,309 kSEK at the end of the

Eltel to install additional 664,000 smart meters in Sweden for SEK 585 million, about EUR 51 million

Eltel's Smart Grids business in Sweden has signed a new contract with Vattenfall Eldistribution AB to install 664,000 new-generation smart electricity meters across the country. The contract is worth SEK 585 million, about EUR 51 million.This contract is an extension of a previous agreement signed in February 2020, where Vattenfall Eldistribution AB decided to utilize the option to order remaining phases of smart electricity meter installations. As a result, throughout the project, Eltel will be installing a total of approximately 900,000 smart electricity meters and technology for about 40,

Dignitana AB Publishes Q1 2023 Interim Report

Revenue reaches record high with EBITDA positive Financial highlights Q1 2023 · Net sales amounted to 21.5 MSEK (15.9), an increase of 35 percent over the same period in 2022. · Operating result amounted to -3.5 MSEK (-6.1). · Net result after financial items amounted to -3.9 MSEK (-6.5). ·  Earnings per share were -0.06 SEK (-0.10). · Cash Balance amounted to 11.7 MSEK (11.3). · Average Daily Treatment Revenue (ADTR)* was 242 TSEK (179), an increase of 35 percent over the same period in 2022. · EBITDA positive for the period. Business highlights during the

Woodspin ramps up production of sustainable, wood-based SPINNOVA® fibre at new zero-emission factory

The first commercial facility producing SPINNOVA® fibre is scaling up production to 1,000 tonnes of sustainable textile fibre annually. 25 May, Jyväskylä, Finland – Finnish sustainable textile pioneer Spinnova and the world's largest pulp producer Suzano have officially opened their first commercial-scale facility producing wood-based SPINNOVA® fibre. Operated by Woodspin – Spinnova and Suzano’s joint venture – the plant will produce 1,000 tonnes of sustainable, recyclable and fully biodegradable textile fibre from responsibly-grown wood each year. This facility marks the first

Interim report for the period 1 January 2023 – 31 March 2023

published at 08:00 on 25 May 2023 Wicket Gaming AB (”Wicket Gaming” or the ”Company”) publishes interim report for the period 1 January 2023 – 31 March 2023.Summary of the period The Group arose during the fourth quarter of 2022. Consequently, the figures presented in this report for the Group do not include any comparison with the corresponding period in the previous year. First quarter 01/01/2023 – 31/03/2023 (Group) · Net sales: SEK 4,606 thousand. · Earnings before interest, taxes, depreciation and amortisation (EBITDA): SEK -2,329 thousand. · Net loss after

Hemnet launches Vägen hem - a podcast about the Swedish housing market

Today, May 25, Hemnet premiered Vägen hem, a podcast which follows and explains the developments in the Swedish housing market. The podcast is hosted by Staffan Tell, PR manager at Hemnet, and Erik Holmberg, market analyst at Hemnet. Property developer Riksbyggen is the exclusive partner for the first six episodes of the podcast.In Vägen hem Staffan and Erik talk about the most important current macro events and their impact on the housing market, as well as analyze and discuss Hemnet's own data. Listeners will also meet exciting guests such as real estate agents, economists and other

Metsä Board has submitted the EIA report for the Kaskinen paperboard mill to the ELY Centre of South Ostrobothnia

Metsä Board Corporation press release 25.5.2023Metsä Board, part of Metsä Group, has submitted the EIA report for the Kaskinen paperboard mill in accordance with the Environmental Impact Assessment Procedure Act to the South Ostrobothnia Regional Economic, Transport and Environment Centre (ELY Centre). The report is open for public comment and opinion from 25.05.2023 to 21.07.2023. The ELY Centre will make the EIA report prepared by Metsä Board available to the public for 60 days for comments and opinions starting on 25 May. During this time, the assessment report will be available on

Interim report January–March 2023

OSLO, NORWAY, May 25, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the first quarter of 2023. The interim report is available as an attached file to this release and on the Company’s website (www.genetic-analysis.com). Below is a summary of the report.Ronny Hermansen, CEO of Genetic Analysis, comments:“As we close Q1 2023, we are proud of the momentum we have built and the progress we have made toward fulfilling a critical need in the healthcare industry. With the launch of our new customer-facing cloud software, GA-map® Analyzer, and the

MindArk Interim Report Q1 2023

MindArk PE AB (publ) ("MindArk", the "Company") hereby announces that the Company's interim report for Q1 2023 has been published.Comment from CEO Henrik Nel Jerkrot: "The first quarter of 2023 has been a continued strong quarter for MindArk where we reach a revenue record for the Q1 period for the third year in a row. Although some of the company's resources are committed to the work on the graphics engine migration, user activity in Entropia Universe has increased by 15%. This speaks to our team's ability to create exciting content for our users that keeps them engaged. The company

TIE Kinetix Signs Contract with Tranzonic for a 100% Cloud-Based Supply Chain Solution

TIE Kinetix , a leader in 100% supply chain digitalization, announced today a new 3-year, $273,000 contract with Tranzonic, a leader in cleaning supply manufacturing. Now that Tranzonic has chosen TIE Kinetix as their service provider for electronic document exchange, they will benefit from a solution that is seamlessly integrated into their Microsoft D365 environment and helps them achieve a fully digitalized and efficient supply chain.Tranzonic’s decision to invest in TIE Kinetix’s EDI-2-FLOW for D365 solution for their EDI services means that their supply chain

Invitation to SAS’ Q2 2023 teleconference

SAS will publish the interim report for the second quarter of the fiscal year 2023 on Thursday, June 1, 2023, at approximately 08.00 AM CEST. A teleconference and webcast for investors, analysts and media will be held at 10.00 AM CEST. Anko van der Werff, President & CEO and Erno Hildén, Executive Vice President & CFO, will present and comment on the report. The presentation will be held in English.   Access via web link (no advance notification is necessary):  https://ir.financialhearings.com/sas-q2-2023 Registration for participation via telephone: https://conference.

Zengun Group AB (publ) Interim Report January – March 2023

“Despite the deteriorated market conditions, Zengun continued its strong growth with a high rate of production in the first three months of the year.” Mick Salonen, President and CEO First quarter •         Net turnover amounted to MSEK 688.6 (596.9) •         EBITDA totalled MSEK 31.9 (30.4), corresponding to an EBITDA margin of 4.6% (5.1) •         Earnings before tax amounted to MSEK 16.4 (15.8) •         Operating cash flow was MSEK 32.9 (57.4) •         Orders received totalled MSEK 537.6 (847.9) •         The order book amounted to MSEK 3,482.2 (3,490.8)

Interim report January-March 2023

STABLE IN A SHRINKING MARKETJanuary-March 2023 · Order bookings amounted to SEK 1,303 million (1,837) · Income amounted to SEK 2,116 million (2,052) · Operating profit amounted to SEK 1 million (36) · Cash flow from operating activities amounted to an outflow of SEK 441 million (5) · Cash flow for the period amounted to an outflow of SEK 65 million (28) · The loss for the period amounted to SEK 10 million (profit 55) · At the end of the period, available cash and cash equivalents totaled SEK 549 million (624) · The equity/assets ratio was 30.1 percent (31.7) ·

Stora Enso issues EUR 1 billion of new green bonds

STORA ENSO OYJ STOCK EXCHANGE RELEASE 25 May 2023 at 09:00 EESTTHIS ANNOUNCEMENT IS NOT BEING MADE IN, AND COPIES OF IT MAY NOT BE DISTRIBUTED OR SENT INTO, THE UNITED STATES, THE UNITED KINGDOM OR JAPAN.Stora Enso has successfully issued two new EUR 500 million green bonds under its EMTN (Euro Medium Term Note) programme. The bonds have 3 and 6.25 year maturities and pay a fixed coupon of 4.00% and 4.25% respectively. The bonds are issued under Stora Enso’s new combined Green and Sustainability-Linked Financing Framework 

There are no items matching the current filter
There are no more items matching the current filter
Back to top